
GENEWIZ SPARK 2026 - Be ready to spark the next wave of discovery!
GENEWIZ SPARK Grant 2026 is back during the GENEWIZ Week to celebrate our 27 years of Fueling Scientific Discovery!
Whether you’re a postgraduate student or an Early Career Researcher within 5 years of completing your Ph.D., the GENEWIZ SPARK Grant is your opportunity to take that idea further.
This year, we’re looking for innovative research projects across four key areas:
- Agriculture
- Antibody and Vaccine Research
- Single Cell Analysis for Immunology, Cell & Gene Therapy (CGT), and Oncology
- Synthetic Biology
At GENEWIZ, we believe promising ideas deserve the opportunity to grow. The GENEWIZ SPARK Grant - Supporting Progressive Advancement in Research and Knowledge - was created to help emerging researchers turn ambitious ideas into meaningful scientific progress.
Through our trusted GENEWIZ Multiomics and Synthesis solutions, we support pharmaceutical, biotechnology, and academic researchers worldwide with high-quality services and data that help accelerate discovery.
For GENEWIZ SPARK 2026, 10 researchers will each receive US$1,000 in GENEWIZ service credits to help advance their proposed research. Winners will also have the opportunity to showcase their research and share their scientific journey with the wider research community.
Simply apply! All applicants (winners or not) will get special discount across our GENEWIZ services*!
An email with the discount will be sent to you at the end of this grant challenge campaign. So why not, just apply!
Please refer to the steps under 'How to Apply' and 'Terms & Conditions' to ensure you fulfil the eligibility.
Your idea could be the next one to SPARK change!
We’re looking for proposals that are bold, original, and impactful, with the potential to advance their fields or unlock new possibilities. Applications will also be evaluated based on feasibility, scientific methodology, and clearly defined research objectives and parameters.
Explore our solutions at GENEWIZ.com and discover how we can help bring your research idea to life. Grant credits can be used across services including:
- Next-Generation Sequencing
- Sanger Sequencing
- Gene Synthesis
- Oligo Synthesis
- Plasmid DNA Preparation
- Gene Editing Services
- And more
Your idea could be the start of something bigger. Apply for GENEWIZ SPARK 2026 today.
Please email inquiries.asia@azenta.com for any clarifications.
Kindly title your email subject as: [Your Country] GENEWIZ SPARK Challenge 2026 - [Brief title of your enquiry]
GENEWIZ SPARK 2026
About GENEWIZ from Azenta Life Sciences
GENEWIZ from Azenta Life Sciences is returning to its roots with a rebranding effort designed to bring back GENEWIZ’s unique identity and the energetic, fun, and highly personalized customer interactions that have distinguished the company since its founding in 1999. GENEWIZ empowers research by providing high-quality, precision-based solutions from research use only to pre-clinical/clinical, enabling scientists to make breakthroughs faster and more efficiently. Key services include Next Generation and Sanger sequencing, gene synthesis, gene-to-discovery solutions including antibody production, viral packaging and mRNA synthesis. For more information visit www.Genewiz.com.
GENEWIZ is part of the larger Azenta family - Azenta, Inc. (Nasdaq: AZTA) which is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful breakthroughs and therapies to market faster.
As part of GENEWIZ rebranding initiative and its longstanding commitment in supporting the research community, we are excited to announce the launch this grant challenge again this year now known as GENEWIZ SPARK 2026!
What is GENEWIZ SPARK?
SPARK stands for Supporting Progressive Advancement in Research and Knowledge.
GENEWIZ SPARK is a grant challenge aimed at providing resources to kickstart and advance the research endeavors of postgraduate students and ECRs. Grant recipients will be able to access invaluable multiomics and synthesis resources by GENEWIZ from Azenta Life Sciences, We will also give these young scientists a platform to showcase their research projects regionally through webinars, seminars and/or other potential forms of collaborations.
The grant program opens for applications on 14th September 2026 at 12:01 a.m. (GMT+08:00) and the deadline for application submission is on 30th November 2026 at 11:59 p.m. (GMT+08:00).
THERE IS NO REQUIREMENT FOR PURCHASE OR PAYMENT OF ANY KIND IN ORDER TO ENTER THIS CHALLENGE.
How To Apply
-
Simply fill in the application form on https://web.genewiz.com/apac-genewiz-spark-grant-2026
Tip: As this is an online form, have your answers ready in another document and copy it over to the webform for submission. - Register a GENEWIZ CLIMS account (if you do not have a GENEWIZ account yet) - Registration
Eligibility
Applicants must meet our eligibility criteria:
-
Ph.D students and Early Career Researcher (within 5 years from your Ph.D graduation) in any research institutions from APAC countries*.
-
The theme of your research follows any one of the application areas below:
-
Agriculture
-
Antibodies and Vaccine
- Single Cell Analysis for Immunology, CGT and Oncology
- Synthetic Biology
-
-
The submission of the grant begins on 14th September 2026 at 12:01 a.m. (GMT+08:00) and ends on 30th November 2026 at 11:59 p.m. (GMT+08:00).
-
The winners will be announced tentatively in January 2027. Applicants are encouraged to check your emails (inbox and junkmail) for any notifications relating to this grant.
GENEWIZ SPARK 2026
NO PURCHASE OR PAYMENT OF ANY KIND IS NECESSARY TO ENTER OR WIN ELIGIBILITY
Participation in the GENEWIZ Grant Challenge is open to individuals professionally engaged in laboratory-based scientific research in the Asia Pacific (APAC) region (excluding Japan and China) and have attained at least the age of majority in their jurisdiction of residence (entrants must, in any event, be at least 18 years of age). Employees, officers, directors, agents, representatives and independent contractors of the Sponsors, its subsidiaries or affiliated companies, together with their immediate family members and members of the same households (whether related or not) are not eligible to participate. Also ineligible are (1) residents of Cuba, Iran, North Korea, Sudan, Syria, the Crimea region of Ukraine, Russia, or any country subject to U.S. embargo; (2) any persons (including businesses, research institutions, government and private organizations, individuals, and other types of legal persons) on the U.S. government's Denied Persons List, Specially Designated Nationals list, Entity List, Unverified List or any other similar list maintained by the U.S. government or any other government to whose laws the Sponsors, its subsidiaries or affiliated companies, the Grant Program or such person is subject, and all individuals employed thereby or otherwise associated therewith; and (3) any persons for whom it would be illegal to participate in or win the Grant Challenge, or with or to whom it would be illegal for the Sponsors to interact or award the prize as contemplated herein. The Grant Challenge is subject to all applicable laws and regulations, and is void where prohibited or where registration, bonding or language translation is required.
HOW TO ENTER
The GENEWIZ Grant Challenge (APAC) begins on 14 September 2026 at 12:01 a.m. (GMT+08:00) and ends on 30 November 2026 at 11 :59 p.m. (GMT+08:00). The contest is open to researchers who have not been the winner for another grant program under Azenta Life Sciences. To enter, participants must submit an online application to the GENEWIZ SPARK Grant Challenge official webpage via https://web.genewiz.com/apac-genewiz-spark-grant-2026. Applications become the property of the Sponsors. The Sponsors make no guarantee or warranty with respect to the security or confidentiality of applications or the application process. By entering, the participant gives permission to the Sponsors to contact the participant regarding the Sponsors' products and services, whether or not the participant is chosen as the winner. In the event that the Sponsors deem a participant to have made multiple applications to enter or to have acted in bad faith with respect to the Grant Challenge, the participant shall be excluded from the Grant Challenge and consequently ineligible to win the prize, as defined below.
SELECTION OF WINNER AND NOTIFICATION
Ten (10) winners will be selected from all qualified applications by a panel of the Sponsors' scientists and staff, who will evaluate applications based on (i) the relevance of the proposed project to the application topics; (ii) the relevance and suitability of the proposed GENEWIZ services to the project; and (iii) the extent to which the proposed project makes effective use of the grant prize. Entrants are not eligible to win multiple prizes in the Grant Challenge. The decision of this panel will be final and binding. The selected winners will be attempted to be notified by email within approximately five (5) business days after evaluation period ends. If the selected winner has not responded to email inquiries within three (3) days, the Sponsors will attempt to contact the winner by telephone. If the winner cannot be reached by telephone within forty-eight (48) hours of the first telephone attempt to notify such winner, the prize may be forfeited and an alternate winner may be selected, based on the criteria set forth above, at the Sponsors' discretion. The odds of winning depend on the number of eligible entries received.
PRIZE DESCRIPTION & CONSUMER DISCLOSURE
Each of the ten prizes consist of a US $1,000 credit toward a single or multiple orders using GENEWIZ from Azenta Life Sciences Multiomics and Synthetic Services as listed on https://genewiz.com/ . Any unused credit unused by the stated deadline below will be forfeited and cannot be transferred to another project. Winners are required to fulfil their obligations in sharing their research through the Sponsor’s marketing collaboration as stated on the GENEWIZ Grant Challenge (APAC) website and/or other equivalent alternatives.
RESTRICTIONS APPLY
Orders using the credit must be confirmed by 31 December 2027. If starting material is to be provided, it must be received by 31 December 2027 and meet our sample submission guidelines as indicated in the quote or as outlined on www.genewiz.com/Public/Resources/Sample-Submission-Guidelines. The credit cannot be combined with other discounts, offers, or promotions. The Sponsors may refuse to award the prize or modify any terms if the winner attempts to redeem the credit on an order which varies significantly from the proposed project in the grant application.[NB1] [JN2] For next generation sequencing projects, the preferred service package, where appropriate, may be used for calculating the list price of the project. The prize may not be transferred or assigned; no substitutions or cash equivalents are allowed. The winner may be required to execute and return an affidavit of eligibility/release of liability/publicity release (where legal) within twenty-one (21) days of notification attempt. If the winner fails to return the affidavit/release by the deadline, the prize will be forfeit and an alternate winner may be selected, based on the criteria set forth above, at the Sponsors' discretion. The participant understands and agrees that no ideas, information or materials that are submitted to or otherwise provided to the Sponsors in connection with the Grant Challenge will be returned, and that the Sponsors make no guarantee or warranty with respect to the security or confidentiality thereof. All taxes on the prize and reporting thereof, and any other costs, fees and expenses relating to the prize or the Grant Challenge, are the sole responsibility of the winner and/or the winner's institution or company. By submitting an application or accepting the prize, the participant agrees on behalf of the participant and the participant's institution or company: (1) to be bound by these official rules; (2) that the Sponsors shall retain full authority, in their sole discretion, to interpret and administer these rules; (3) that any dispute with regard to the conduct of the Grant Challenge, rule interpretation or award of the prize, shall be resolved by the Sponsors, whose decision shall be binding and final; and (4) to be bound by all decisions and interpretations made in good faith by the Sponsors. Furthermore, the participant represents and warrants that: (1) the participant meets the eligibility requirements of the Grant Challenge; (2) the participant has obtained all required authorizations and permissions from the participant's institution or company; (3) entering into the Grant Challenge does not and will not violate any law or regulation, or any of the institution's or company's rules or policies; and (4) the information contained in the application is true and correct in all material respects and is owned or rightfully possessed by the participant without restriction on disclosure. The Sponsors may refuse to award the prize if the Sponsors determine in their sole discretion that doing so would likely result in a violation of an applicable law, rule, or policy. Grant winner samples should not be pathogenic.
USE OF WINNER'S NAME
The participant acknowledges and agrees that, if the participant is selected as the winner, the participant's name, biographical information, likeness, the name of the participant's institution or company and the project title (excluding further project details) may, without further compensation, be published on one or more Sponsor website(s) and, at the Sponsors' discretion, through social media. By accepting the prize, the winner grants to the Sponsors, on behalf of the winner and the winner's institution or company, the right, at any time and from time to time, to print, publish, broadcast and use, worldwide and in any media now known or hereafter developed (including, but not limited to, social media, the Internet and the world wide web), the winning participant's name, biographical information, (if provided by the participant) image, likeness, the name of the winning participant's institution or company and the project title (excluding further project details).
INDEMNITY, DISCLAIMER & LIMITATION OF LIABILITY
By participating in the Grant Challenge, the participant agrees on behalf of the participant and the participant's institution or company to release, discharge, indemnify and hold harmless the Sponsors and their respective affiliates, subsidiaries, officers, directors, employees, agents and representatives from all liability for any injury, loss or damage, including death or property damage, due in whole or part, directly or indirectly, to the participation in the Grant Challenge or the acceptance, possession, use or misuse of the prize. The Sponsors have not made any warranty, representation, or guarantee, express or implied, in fact or in law, with respect to the prize, including, without limitation, to such prize's quality or fitness for a particular purpose. THE SPONSORS ARE NOT RESPONSIBLE FOR LOST, LATE, STOLEN, INCOMPLETE, ILLEGIBLE, INACCURATE, UNDELIVERED, DELAYED OR MISDIRECTED ENTRIES, OR FOR ANY COMPUTER, INTERNET, EMAIL, TELEPHONE OR TECHNICAL MALFUNCTIONS OR DELAYS, OR FOR ANY HUMAN ERRORS THAT OCCUR IN THE PROCESSING, TRANSMISSION OR RECEIPT OF ENTRIES, OR FOR INACCURATE TRANSCRIPTION OF ENTRY INFORMATION, OR IF THE GRANT PROGRAM IS NOT CAPABLE OF BEING CONDUCTED AS PLANNED, INCLUDING BUT NOT LIMITED TO INFECTION BY COMPUTER VIRUSES, BUGS, TAMPERING, UNAUTHORIZED INTERVENTION, FRAUD, TECHNICAL FAILURES, OR OTHER CAUSES BEYOND THE CONTROL OF THE SPONSORS. IN NO EVENT SHALL THE SPONSORS OR THEIR RESPECTIVE AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, EMPLOYEES, AGENTS OR REPRESENTATIVES BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, EXEMPLARY OR PUNITIVE DAMAGES WHATSOEVER ARISING OUT OF OR IN CONJUNCTION WITH PARTICIPATION IN THE GRANT PROGRAM OR THE ACCEPTANCE, POSSESSION, USE OR MISUSE OF THE PRIZE, WHETHER BASED ON WARRANTY, CONTRACT, TORT, STRICT LIABILITY, OR ANY OTHER LEGAL THEORY, AND WHETHER OR NOT ANY OF THEM ARE ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THE FOREGOING LIMITATION OF LIABILITY SHALL APPLY TO THE FULLEST EXTENT PERMITTED BY LAW. THE SPONSORS' TOTAL AND CUMULATIVE LIABILITY ARISING OUT OF OR IN CONNECTION WITH THE GRANT PROGRAM SHALL IN NO EVENT EXCEED THE TOTAL VALUE OF THE PRIZE.
MISCELLANEOUS
The Sponsors reserve the right to suspend, modify, cancel or terminate the Grant Challenge without advance notice, including, without limitation, in the event of any act, occurrence or reason that it believes would compromise the legality, integrity, administration or fairness of the Grant Challenge. If one or more provisions of these official rules are held to be invalid or unenforceable by a court of competent jurisdiction, the remaining provisions shall be valid and enforceable. These official rules are governed by and shall be construed by the laws of the State of New Jersey, USA, without application of its choice of law principles. Should there be a conflict between the laws of the Commonwealth of Massachusetts and any other laws, the conflict will be resolved in favor of the laws of the Commonwealth of Massachusetts. Any dispute that may arise hereunder shall be brought solely in the appropriate state or federal courts sitting in Middlesex County, Massachusetts, USA and participant consents to the personal jurisdiction and venue thereof. The failure of the Sponsors to comply with any provision of these official rules due to civil unrest, threat of or actual acts of terrorism or war, embargoes, governmental actions, acts of God, earthquakes, floods, storms, fires, supplier delay, accidents, explosions, epidemics, quarantine restrictions, or other such contingencies beyond the control of the Sponsors, shall not be considered a breach of these rules.
SPONSORS
Azenta Singapore Pte. Ltd., 2 International Business Park, #02-30/37, Singapore 609930
Azenta US, Inc. (d/b/a GENEWIZ), 115 Corporate Boulevard, South Plainfield, NJ 07080, USA.
4titude Limited, The North Barn, Surrey Hills Business Park, Damphurst Lane, Wotton, Surrey RH5 6QT, UK.
© Copyright 2026, Azenta, Inc. All rights reserved. All other trademarks are the sole property of their respective owners.